Related Experiment Video
Updated: Sep 2, 2025
09:14
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
2.5K
Inflammation and Severe Cerebral Venous Thrombosis
Shuyuan Hu1,2, Hangil Lee3, Haiping Zhao4
1Department of Emergency, Xuanwu Hospital, Capital Medical University, Beijing, China.
Frontiers in Neurology
|August 8, 2022
Summary
Severe cerebral venous thrombosis (CVT) involves neuroinflammation, with activated immune cells like microglia and astrocytes exacerbating brain injury. Anti-inflammatory therapies show promise for treating this condition.
Area of Science:
- Neuroscience
- Immunology
- Vascular Neurology
Background:
- Cerebral venous thrombosis (CVT) is a rare but significant cause of stroke, particularly in young adults and children.
- Severe CVT presents with serious neurological deficits and poor outcomes, with unclear underlying mechanisms beyond venous return disorder.
- Emerging evidence highlights a critical role for neuroinflammation in the pathophysiology of severe CVT.
Purpose of the Study:
- To review the current literature on the involvement of inflammation in the pathophysiology of severe CVT.
- To explore the potential of anti-inflammatory interventions for managing severe CVT.
- To inform the understanding of severe CVT mechanisms and guide novel therapeutic strategies.
Main Methods:
- Literature review of preclinical and clinical studies on severe CVT and neuroinflammation.
- Analysis of the roles of microglia, astrocytes, and neutrophils in CVT-induced brain injury.
- Examination of inflammatory mediators, pathways, and biomarkers in CVT progression.
Main Results:
- Neuroinflammation, involving activated microglia, astrocytes, and neutrophils, contributes significantly to brain injury in severe CVT.
- Cytokine release from activated microglia leads to blood-brain barrier disruption, edema, and infarction.
- Inflammatory cell morphology and mediator expression change with CVT progression, offering potential biomarkers.
Conclusions:
- Inflammation is a key driver of severe CVT pathophysiology and associated brain damage.
- Anti-inflammatory therapies represent a promising avenue for treating severe CVT.
- Further research into inflammation mechanisms and targeted anti-inflammatory strategies is crucial for improving CVT patient outcomes.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
37
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
37
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
30
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
30
01:29Venous Thrombosis III: Interprofessional Care
18
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
01:30Venous Thrombosis IV: Nursing Management
21
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
21
01:19Veins of Head and Neck
2.7K
The blood drainage from the head and neck is primarily managed by three pairs of veins: the external jugular, internal jugular, and vertebral veins. The external jugular veins drain superficial scalp and face structures, passing over the sternocleidomastoid muscles to empty into the subclavian veins.
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
2.7K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
867
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
867